Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024 ...Middle East

PR Newswire - Economy
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024
MUMBAI, India, Jan. 30, 2024 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and consolidated results for the Third Quarter (Q3) and Nine Months (9M) ended 31st December 2023. Consolidated...

Read More Details
Finally We wish PressBee provided you with enough information of ( Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024 )

Apple Storegoogle play

Also on site :



Latest News